12/12/2014

Filing of IND for Connective Tissue Disease Associated Interstitial Lung Disease

09/29/2014

Notice of Exercise Price of Stock Option etc

09/12/2014

Notice of Granting Stock Option to Board of Directors

09/04/2014

Tokyo Administrative Office Relocation

09/01/2014

Re-assignment of Industry Category

07/01/2014

F351 Phase II Clinical Trial Approval

05/09/2014

Patent Allowance for Etuary and F351 in the U.S.

03/19/2014

Notice for completion of the registration of incorporation of a subsidiary

02/27/2014

Notice of Changing of Accounting Auditor

02/27/2014

Announcement of the 13th Annual General Shareholder Meeting

02/27/2014

Notice for the drug price and sales commencement for Etuary

02/03/2014

Notice for Exercise of the 37th Round of Stock Options in January, 2014

01/27/2014

Notice for establishment of distributors

01/17/2014

Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option

01/14/2014

Notice for F647 commercial name